Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-005606
Filing Date
2025-04-28
Accepted
2025-04-28 06:01:42
Documents
22
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A qure-20250611xdef14a.htm   iXBRL DEF 14A 1958546
2 GRAPHIC qure-20250611xdef14a_a001.jpg GRAPHIC 9542
3 GRAPHIC qure-20250611xdef14a_a002.jpg GRAPHIC 2513
4 GRAPHIC qure-20250611xdef14a_a016.jpg GRAPHIC 32945
5 GRAPHIC qure-20250611xdef14a_a017.jpg GRAPHIC 37085
6 GRAPHIC qure-20250611xdef14a_bg001.jpg GRAPHIC 150449
7 GRAPHIC qure-20250611xdef14a_bg002.jpg GRAPHIC 119020
  Complete submission text file 0001558370-25-005606.txt   3760985

Data Files

Seq Description Document Type Size
8 EX-101.SCH qure-20250611.xsd EX-101.SCH 4543
9 EX-101.DEF qure-20250611_def.xml EX-101.DEF 3508
10 EX-101.LAB qure-20250611_lab.xml EX-101.LAB 5190
11 EX-101.PRE qure-20250611_pre.xml EX-101.PRE 4677
24 EXTRACTED XBRL INSTANCE DOCUMENT qure-20250611xdef14a_htm.xml XML 275498
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36294 | Film No.: 25875812
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)